Clover Biopharmaceuticals Financial Health
Financial Health criteria checks 1/6
Clover Biopharmaceuticals has a total shareholder equity of CN¥-668.1M and total debt of CN¥294.1M, which brings its debt-to-equity ratio to -44%. Its total assets and total liabilities are CN¥4.7B and CN¥5.4B respectively.
Key information
-44.0%
Debt to equity ratio
CN¥294.06m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.62b |
| Equity | -CN¥668.14m |
| Total liabilities | CN¥5.36b |
| Total assets | CN¥4.69b |
Recent financial health updates
Companies Like Clover Biopharmaceuticals (HKG:2197) Are In A Position To Invest In Growth
Mar 17
Is Clover Biopharmaceuticals (HKG:2197) In A Good Position To Deliver On Growth Plans?
Nov 29Will Clover Biopharmaceuticals (HKG:2197) Spend Its Cash Wisely?
Aug 31We're Hopeful That Clover Biopharmaceuticals (HKG:2197) Will Use Its Cash Wisely
Apr 28Recent updates
Companies Like Clover Biopharmaceuticals (HKG:2197) Are In A Position To Invest In Growth
Mar 17Is Clover Biopharmaceuticals (HKG:2197) In A Good Position To Deliver On Growth Plans?
Nov 29Will Clover Biopharmaceuticals (HKG:2197) Spend Its Cash Wisely?
Aug 31We're Hopeful That Clover Biopharmaceuticals (HKG:2197) Will Use Its Cash Wisely
Apr 28Clover Biopharmaceuticals, Ltd. (HKG:2197) Shares Could Be 28% Below Their Intrinsic Value Estimate
Feb 05Financial Position Analysis
Short Term Liabilities: 2197 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: 2197 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: 2197 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: 2197's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2197 has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: Insufficient data to determine if 2197 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.